Showing 141 - 160 results of 8,976 for search '(( 5 ppm decrease ) OR ((( 50 nn decrease ) OR ((( 50 we decrease ) OR ( 50 μ decrease ))))))', query time: 0.64s Refine Results
  1. 141
  2. 142
  3. 143
  4. 144
  5. 145
  6. 146
  7. 147
  8. 148
  9. 149
  10. 150
  11. 151
  12. 152
  13. 153
  14. 154
  15. 155
  16. 156

    Antimicrobial activity of RP-1 peptide conjugate with ferrocene group by Natalia C. S. Costa (8626206)

    Published 2020
    “…The Fc-RP1 presented anti-amastigote activity against <i>Leishmania amazonensis</i> (IC<sub>50</sub> = 0.25 μmol L<sup>–1</sup>). In comparison with amphotericin B, a second-line drug approved for leishmaniasis treatment, (IC<sub>50</sub> = 0.63 μmol L<sup>-1</sup>), Fc-RP1 was more active and showed a 2.5-fold higher selectivity index. …”
  17. 157

    Synthesis and Biological Evaluation of New Chalcogen Semicarbazone (<i>S</i>, <i>Se</i>) and Their Azole Derivatives against Chagas Disease by Mercedes Rubio-Hernández (20036142)

    Published 2024
    “…Three compounds were selected, based on their activity against the intracellular amastigotes (EC<sub>50</sub> < 1 μM, SI > 10) and cruzain (IC<sub>50</sub> < 100 nM, SI > 5.55) which compared favorably with the approved drug, Benznidazole, and the well-established cruzain inhibitor K777. …”
  18. 158

    Synthesis and Biological Evaluation of New Chalcogen Semicarbazone (<i>S</i>, <i>Se</i>) and Their Azole Derivatives against Chagas Disease by Mercedes Rubio-Hernández (20036142)

    Published 2024
    “…Three compounds were selected, based on their activity against the intracellular amastigotes (EC<sub>50</sub> < 1 μM, SI > 10) and cruzain (IC<sub>50</sub> < 100 nM, SI > 5.55) which compared favorably with the approved drug, Benznidazole, and the well-established cruzain inhibitor K777. …”
  19. 159

    Potent 5‑Cyano-6-phenyl-pyrimidin-Based Derivatives Targeting DCN1–UBE2M Interaction by Wenjuan Zhou (115285)

    Published 2019
    “…After finding a novel inhibitor <b>DC-1</b> with IC<sub>50</sub> = 1.2 μM, we performed a series of chemical optimizations, which finally led to the discovery of a potent thiazole containing 5-cyano-6-phenylpyrimidin-based inhibitor <b>DC-2</b> (IC<sub>50</sub> = 15 nM). …”
  20. 160